Higher weight loss (1% reduction in weight from baseline was associated with a 3.1% [95% CI, 2.9%-3.2%] lower hazard of discontinuation for patients with type 2 diabetes and a 3.3% [95% CI, 3.2%-3.5%] lower hazard of discontinuation for patients without type 2 diabetes) and higher income (type 2 diabetes only
Although there is no absolute contraindication to using these medications together, their opposing metabolic effectsparticularly on weight and blood glucoserequire careful clinical consideration
Battle misconceptions head-on:GLP-1 brands confront bias and stigma with clear, stigma-reducing content proactively addressing emotional and informational hurdles to adherence and long-term engagement
Fortino and his staff of well-trained nurse practitioners provide personalized weight management programs that include medications like Semaglutide and Tirzepatide, along with appetite suppressant medication such as Phentermine
Long-Term Metabolic Benefits: Beyond weight loss, GLP-1 therapy supports improved cholesterol levels, lower blood pressure, and reduced cardiovascular risks